Severe pulmonary toxicity in patients with leiomyosarcoma after treatment with gemcitabine and docetaxel

Invest New Drugs. 2007 Jun;25(3):279-81. doi: 10.1007/s10637-006-9030-7. Epub 2007 Jan 13.

Authors

Stephan A Veltkamp¹, Jetske M Meerum Terwogt, Michel M van den Heuvel, Hester H van Boven, Jan H M Schellens, Sjoerd Rodenhuis

Affiliation

¹ Division of Experimental Therapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. s.veltkamp@nki.nl

PMID: 17221305
DOI: 10.1007/s10637-006-9030-7

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Arm / pathology*
Deoxycytidine / administration & dosage
Deoxycytidine / analogs & derivatives
Docetaxel
Fatal Outcome
Female
Gemcitabine
Humans
Leiomyosarcoma / drug therapy*
Leiomyosarcoma / secondary
Middle Aged
Ovarian Neoplasms / drug therapy*
Ovarian Neoplasms / pathology
Respiratory Distress Syndrome / chemically induced*
Respiratory Distress Syndrome / pathology
Severity of Illness Index
Taxoids / administration & dosage
Tomography, X-Ray Computed
Treatment Outcome

Substances

Taxoids
Deoxycytidine
Docetaxel
Gemcitabine